Related Experiment Video
Updated: Oct 3, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Pathogenic variant of RBM20 in a multiplex family with hypertrophic cardiomyopathy
Natsuko Inagaki1,2, Takeharu Hayashi3,4, Yasuyoshi Takei5
1Department of Cardiology, Tokyo Medical University, Tokyo, Japan. abenatsu@wb3.so-net.ne.jp.
Insights
RNA-binding protein 20 (RBM20) variants are linked to hypertrophic cardiomyopathy (HCM). A specific RBM20 variant, p.Arg636His, previously associated with dilated cardiomyopathy (DCM), was identified in a family with HCM, suggesting a novel role for RBM20 in HCM.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Etiology of Cardiomyopathies
Background:
- RNA-binding protein 20 (RBM20) is primarily known as a disease-causing gene for dilated cardiomyopathy (DCM).
- Familial hypertrophic cardiomyopathy (HCM) has diverse genetic underpinnings, but novel causative genes are continually being identified.
- The p.Arg636His missense variant in RBM20 has been previously reported as pathogenic in families with DCM.
Purpose of the Study:
- To investigate the genetic basis of familial hypertrophic cardiomyopathy (HCM) in a family.
- To determine if the RBM20 gene and its variants play a role in the pathogenesis of HCM.
- To evaluate the p.Arg636His variant of RBM20 as a potential causative factor for familial HCM.
Main Methods:
- Clinical evaluation of proband and family members presenting with hypertrophic cardiomyopathy (HCM).
- Genetic sequencing to identify variants in candidate genes, including RBM20.
- Segregation analysis of the identified RBM20 variant within the affected family.
Main Results:
- The proband presented with the dilated phase of hypertrophic cardiomyopathy (HCM).
- The mother of the proband also had a history of hypertrophic cardiomyopathy (HCM).
- Both the proband and the mother carried the RBM20 p.Arg636His missense variant, which was previously associated with dilated cardiomyopathy (DCM).
Conclusions:
- The RBM20 p.Arg636His variant is a potential causative factor for hypertrophic cardiomyopathy (HCM) in this familial case.
- RBM20 may represent a novel causative gene for hypertrophic cardiomyopathy (HCM), expanding its known clinical spectrum beyond DCM.
- Further research is warranted to elucidate the precise mechanisms by which RBM20 variants contribute to HCM pathogenesis.
Abstract:
RBM20 is a disease-causing gene associated with dilated cardiomyopathy (DCM). The proband presented with the dilated phase of hypertrophic cardiomyopathy (HCM), and the mother also suffered from HCM. A missense variant of RBM20, p.Arg636His, previously reported as pathogenic in several families with DCM, was found in both the proband and the mother. Therefore, RBM20 p.Arg636His could be the causative variant for this familial HCM, and RBM20 might be a novel causative gene for HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease I: Introduction
Animal Mitochondrial Genetics

